Navigation Links
Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
Date:10/21/2013

y of ENMD-2076 in triple-negative breast cancer, a Phase 2 study of ENMD-2076 in advanced/metastatic soft tissue sarcoma, and is expecting to initiate a Phase 2 study in ovarian clear cell carcinoma.  The Company is headquartered in Rockville, Maryland and has a wholly-owned subsidiary in Beijing, China.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

Forward Looking Statements           
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals.  Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate or future candidates; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid®
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
2. Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
3. Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
4. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
5. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
6. Data From Post-Hoc Analyses Presented at EASD Examine Safety Profile of Linagliptin in Adults with Type 2 Diabetes
7. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
8. LipoScience Announces Data Presented at the 2013 American Diabetes Association Meeting
9. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
10. Ibrutinib Monotherapy Clinical Trial Data in Patients with Waldenstroms Macroglobulinemia Presented at the International Conference on Malignant Lymphoma in Lugano, Switzerland
11. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Voalte, the ... global leader in purpose-built wireless communications, today announced ... Regional), a 104-bed acute-care facility in ... the Voalte One™ solution on Spectralink PIVOT™ purpose-built ... Spectralink named Voalte a member of its AIMS ...
(Date:7/28/2015)... 28, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... underwritten public offering of 6,666,667 shares of its ... $11.25 per share. The gross proceeds to Egalet ... $75 million, before deducting the underwriting discounts and ...
(Date:7/28/2015)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... (AACC) 2015 Clinical Lab Expo today by introducing ... educational initiative that demonstrates how Roche is partnering ... laboratory. The new LabLeaders initiative ( ... the people within them through insight from industry ...
Breaking Medicine Technology:Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 2Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 3Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 4
... , TAI,AN, China, ... (Nasdaq: CBPO ) ("China Biologic," or,the "Company"), one of the ... received approval to list its,common stock on the NASDAQ Global Market. ... begin trading on the NASDAQ on,Wednesday, December 2, 2009, until which ...
... SAN DIEGO, Dec. 1 ADVENTRX Pharmaceuticals, Inc. (NYSE ... recently completed preclinical study has affirmed the bioequivalence and ... Poong Pharmaceuticals, ADVENTRX,s partner for ANX-514 in South Korea, ... , "Our independent confirmation of the bioequivalence and comparable ...
Cached Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3
(Date:7/28/2015)... Nashville, Tenn. (PRWEB) , ... July 28, 2015 ... ... has added the SmileCareClub Invisible Aligner System to its online product ... , By using a teledentistry model and cloud-based technology, SmileCareClub allows patients to ...
(Date:7/28/2015)... Wayne, PA (PRWEB) , ... July 28, 2015 ... ... that its Board of Directors has authorized the Company, from time to time ... with an aggregate value of up to $25 million. Repurchases will be made ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... services to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... evidence based. It provides physicians who are anticipating making a subspecialty referral ...
(Date:7/28/2015)... ... 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta Center ... Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for ... in the metro area as one of the most respected doctors in Reproductive Endocrinology. ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published ... Fibromyalgia, Study Says " sheds light on a possible new treatment option for people ... months of regular HBOT sessions, at least five per week, patients experienced a significant ...
Breaking Medicine News(10 mins):Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3
... - Region,s Fastest Growing Private Company* Delivers Quality, ... in Patients, Needs -, GLENDALE, Calif., Nov. ... (2005 through 2007) earned it the status as ... the region,s top business media,Lakeside Systems, Inc. (Lakeside) ...
... Increases Fund Size for Venture Team by 30%, ... Ventures (, http://www.morgenthaler.com/ventures ), a leading venture ... today that it has exceeded its,fundraising goal and ... $400,million. This brings the firm,s total capital under ...
... PLC Systems Inc.,(Pink Sheets: PLCSF), a company ... today stated that, following the,delisting of its common ... Stock Exchange) on Monday, November 10, 2008, the ... its common stock listing to the,OTCBB. Until that ...
... articles that stress African-American health disparities, like higher ... black patients from being screened for cancer, according ... are more likely to be tested for cancer ... among African-American cancer patients. , While the medical ...
... International Conference on Wireless ... Identification in Milan, HATBORO, Pa., ... of enterprise mobility and advanced,wireless asset tracking solutions for the healthcare ... on the predictive value of identification technology at the ID,WORLD International ...
... Closed in 2008, According to New Report,from HealthLeaders-InterStudy, ... provider of managed care market intelligence, reports that ... better than health systems,in other parts of the ... to the new Southern New Jersey Market Overview, ...
Cached Medicine News:Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 2Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 3Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 4Health News:Morgenthaler Closes Ninth Fund at $400 Million 2Health News:Morgenthaler Closes Ninth Fund at $400 Million 3Health News:Morgenthaler Closes Ninth Fund at $400 Million 4Health News:PLC Systems Updates Common Stock Listing Status 2Health News:Messages of hope work better in motivating black patients to seek early screening for cancer 2Health News:InfoLogix CEO to Address Hidden Value of ID Technology at International Conference 2Health News:InfoLogix CEO to Address Hidden Value of ID Technology at International Conference 3Health News:Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions 2Health News:Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions 3
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... system continues the "Consensus Concept" approach to ... diversified experience of a Scientific Advisory Board. ... that incorporates state-of-the-art features. Consensus Knee implants ... implant stability and allow near normal kinematics. ...
Medicine Products: